Sleep apnea

Disease1 paper

Humans1

Latest

International Journal of General MedicineReview6 h

Sleep Disturbances and Sarcopenia in Older Adults: Clinical Associations, Potential Mechanisms, and Management Strategies

Sleep MedicineHumansYesterday

Obstructive sleep apnea symptom phenotypes and physical health approximately 5 years later in the Sleep Heart Health Study

medRxivHumansPreprintYesterday

REM sleep EEG slowing signals basal forebrain integrity in older adults with subjective and mild cognitive impairment

NeurologyHumans2 Oct

Plasma p-tau217 yields discordant Alzheimer results in 8.5% of adults

False-negative blood results occurred in 5.6% of participants compared with false positives in 2.8%, with mismatches tied to kidney function, BMI, and…False-negative blood results occurred in 5.6% of participants compared with false positives in 2.8%, with mismatches tied to kidney function, BMI, and clinical stage.

Polish Archives of Internal MedicineHumans2 Oct

Risk factors for pulmonary mortality in patients with obstructive sleep apnea: a competing risk analysis integrating Cox regression, random survival forests, and unsupervised clustering

The New England Journal of MedicineHuman trial1 Oct

Retatrutide reduces weight and pain in adults with obesity

Mean body weight fell up to 25.0% with retatrutide versus 3.9% on placebo over 80 weeks in adults with obesity.Mean body weight fell up to 25.0% with retatrutide versus 3.9% on placebo over 80 weeks in adults with obesity.

PLOS OneHumans1 Oct

Age- and sex-stratified prevalence of obstructive sleep apnea and stroke risk comorbidities: A large cross-sectional EHR study

Research SquareHumansPreprint30 Sep

Long-Term Cardiovascular Outcomes of Obstructive Sleep Apnea by Adiposity Phenotype: A Korean Nationwide Cohort Study

European Journal of Internal MedicineHumans30 Sep

Respiratory-hypoxic burden and multimorbidity-related vulnerability are distinct dimensions of obstructive sleep apnea: A retrospective cohort analysis

Canadian Agency for Drugs and Technologies in Health, OttawaReview30 Sep

Tirzepatide (Zepbound): Indication: For once-weekly administration for chronic weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity, in adults with an initial body mass index of: 30 kg/m2 or greater (obesity), or 27 kg/m2 to less than 30 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, prediabetes, type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular disease): Reimbursement Recommendation

Sleep apnea

Latest

Related